Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm

Esophageal Stricture Clinical Trial

Official title:
Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm：a Randomized Controlled Trial

Status Completed

Clinical Trial Summary

The method of esophageal endoscopic submucosal dissection (ESD) to remove superficial esophageal neoplasms has gained widespread acceptance as an alternative to surgery recently these years especially in Asian countries. However, besides of perforation and bleeding, another complication postoperative esophageal stricture is frequently observed after the removal of large-sized esophageal neoplasms by ESD. Dysphagia caused by postoperative stricture substantially decreases the patient's quality of life, requiring further therapy. Although the exact incidence is unknown, esophageal stricture is supposed to be related to the extent of the circumference being resected. In previous study by Ono et al，it is reported that 90% of patients with lesions of circumferential extension of more than three-fourths experienced postoperative stricture after esophageal ESD. There were some reported studies exploring new ways to prevent esophageal stricture after ESD, such as oral prednisolone and local corticosteroid injection. Corticosteroids can inhibit not only collagen synthesis but also enhance collagen breakdown, thereby inhibiting stricture formation. Some studies reveled that just oral prednisolone oral is effective option for the prevention of post-ESD stricture. However, most of the reported studies were non RCTs with small sample. In the primary study, the investigators search a new method of combination of both oral and local injection to prevent esophageal stricture，as a result，stricture at 8 weeks after ESD was found in 19 of 36 patients in the no corticosteroid group but only 4 of 34 in the corticosteroid group. Unfortunately，the study was also retrospective. So, the investigators plan to undertake a prospective, randomized controlled trial to evaluate the prophylactic effects of combination of local steroid injection with oral steroid administration for esophageal stenoses complicating extensive ESD.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03039608
Study type	Interventional
Source	Shanghai Zhongshan Hospital
Contact
Status	Completed
Phase	N/A
Start date	February 10, 2017
Completion date	November 10, 2018

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04372784` - Cryoablation for Benign Gastrointestinal Anastomotic Strictures	N/A
Recruiting	`NCT05581173` - Self-Assembling Matrix Forming Gel to Prevent Stricture Formation
Terminated	`NCT04406428` - NKI Therapy Compared to Usual Care of Recurrent Esophagogastric Anastomotic Strictures	N/A
Recruiting	`NCT00551824` - Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children	N/A
Completed	`NCT04284826` - Mitomycin-C Injection Therapy in Refractory Esophageal Stricture	N/A
Terminated	`NCT03898661` - Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures	Early Phase 1
Withdrawn	`NCT04730076` - Balloon Dilation Methods for Benign Esophageal Stricture	N/A
Active, not recruiting	`NCT03885310` - INGEST I Pilot Study	N/A
Completed	`NCT02069847` - Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy	Phase 2
Terminated	`NCT02354716` - EndoFLIP Use in Upper GI Tract Stenosis
Recruiting	`NCT05561114` - Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus	Phase 3
Not yet recruiting	`NCT04524897` - The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children	Phase 4
Not yet recruiting	`NCT04221867` - Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Esophageal Strictures (ESOGRAFT)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.